Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.58 USD | -13.45% |
|
-42.57% | -30.83% |
06-27 | X4 Pharmaceuticals Shares Fall After Trail Data Announced on Chronic Blood Disease Treatment | MT |
06-27 | Transcript : X4 Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.83% | 97.4M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- XFOR Stock
- News X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Insider Sold Shares Worth $168,371, According to a Recent SEC Filing